Matching the right patient with the right trial at the right time.

Deep Lens Trial Link accelerates oncology clinical trial enrollment by connecting trial sponsors to community oncology practices at scale.

For Providers
For Trial Sponsors
AdobeStock_236734146_edit_crop-2

85%

of clinical trials

fail to meet

planned timelines

11%

of study sites

won't enroll

a single patient

1 in 33

Adult cancer
patients participate
in clinical trials

Deep Lens accelerates clinical trial enrollment

Precision medicine changed the game in oncology clinical trials. Biomarkers can confidently identify eligible patients, but result in competition for patients at care sites. By focusing on community oncology, Deep Lens is helping to open new doors for clinical trial managers. The result is a 300% increase in accrual rates. Learn more about how we accelerate clinical trials below.

homepage-comm-2_web

Community Oncology Focused

The Deep Lens Unity Network is the fastest growing community oncology network in the country. Check out all the benefits of membership here.

homepage-comm-1_web

Experienced Clinical Staff

Dedicated clinical research coordinators work with care teams to pre-screen eligible patients. Spend more time on patient care and less on chart review.

homepage-comm-3_web

AI-Powered Patient Identification

VIPER is Deep Lens’ AI-powered platform that identifies patients based on trial criteria. Easy to use dashboards ensure your enrollment goals stay on track.

Request a real-time feasibility dashboard to see how Deep Lens can accelerate your trial enrollment

 

Deep Lens RTF Dashboard Mockup

I am encouraged that Deep Lens has developed a promising solution to tackle some of the underlying obstacles that are challenging to our sites

- James Langford
Vice President of Clinical Operations, AIVITA Biomedical

Trusted by these partners:

slider_astraZeneca@2x
AlabamaOncology-logo
Altru-logo
PCR-logo
SHO-logo
HawaiiCancerCare-Logo
Bbroome-logo
Icon Logo
TD2 Logo